Latest News for: Vtv

Edit

Vtv Therapeutics Will Participate In INNODIA Symposium At The EASD 61St Annual Meeting

MENA FN 16 Sep 2025
(MENAFN - GlobeNewsWire - Nasdaq) Company to share new independent research on TTP-RA, vTv's oral RAGE antagonistHIGH POINT, N.C., Sept. 15, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq ... .
Edit

vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting

Nasdaq Globe Newswire 16 Sep 2025
Company to share new independent research on TTP-RA, vTv’s oral RAGE antagonist. Company to share new independent research on TTP-RA, vTv’s oral RAGE antagonist ... .
Edit

Regulation FD Disclosure (Form 8-K) (vTv Therapeutics Inc)

Public Technologies 10 Sep 2025
On September 10, 2025, vTv Therapeutics, Inc., (the "Company") will participate in a fireside chat from 2.35 PM - 3.10 PM EST during the Morgan Stanley 23rd Annual Global Healthcare Conference ... Disclaimer. vTv Therapeutics Inc ... (noodl.
Edit

VTV urged to foster national value system of patriotism, creativity

Vietnam News 08 Sep 2025
VTV, as a key multimedia communications agency, must strengthen its position as a pillar of trust and consensus, and remain a reliable voice of the Party, State and people. He urged VTV to remain ...
Edit

Statement of Changes in Beneficial Ownership (Form 4) (vTv Therapeutics Inc)

Public Technologies 05 Sep 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... 2 ... vTv Therapeutics Inc ... C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310 3 ... C/O VTV THERAPEUTICS INC ... vTv Therapeutics Inc.
Edit

Vtv Therapeutics To Participate In Upcoming September Investor Conferences

MENA FN 04 Sep 2025
(MENAFN - GlobeNewsWire - Nasdaq) HIGH POINT, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq. VTVT), a late-stage biopharmaceutical company focused on the development of ... .
Edit

UPDATE -- Vtv Therapeutics To Participate In Upcoming September Investor Conferences

MENA FN 04 Sep 2025
(MENAFN - GlobeNewsWire - Nasdaq) HIGH POINT, N.C., Sept. 03, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq. VTVT), a late-stage biopharmaceutical company focused on the development of ... .
Edit

VTV Celebrates 55th Anniversary (ABU - Asia-Pacific Broadcasting Union)

Public Technologies 03 Sep 2025
Since its inaugural broadcast in 1970, VTV has evolved from a modest state-run channel into a comprehensive media network serving millions of Vietnamese viewers ... Over five decades, VTV has expanded ...
Edit

Dechert Advises vTv Therapeutics on US$80 Million PIPE With Leading Healthcare Institutional Investors and T1D Fund (Dechert LLP)

Public Technologies 03 Sep 2025
Dechert advised vTv Therapeutics Inc ... vTv Therapeutics is a late-stage biopharmaceutical company focused on developing oral, small molecule drug candidates intended to help treat people living with diabetes and other chronic diseases.
Edit

vTv Therapeutics Announces $80 Million Private Placement with Leading Healthcare Institutional Investors and the T1D Fund

Nasdaq Globe Newswire 02 Sep 2025
Proceeds to fund ongoing CATT1 Phase 3 trial and continued development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes ... .
Edit

Material Agreement (Form 8-K) (vTv Therapeutics Inc)

Public Technologies 02 Sep 2025
) Item 1.01. Entry into a Material Definitive Agreement. Private Placement of Class A Common Shares and Pre-FundedWarrants. On August 29, 2025, vTv Therapeutics Inc ... Private Placement Registration Rights Agreement ... Disclaimer. vTv Therapeutics Inc ... (noodl.
Edit

VTV is a sinkhole of novelty songs

Boing Boing 21 Aug 2025
When I read its latest presentation, VTV, describe itself as "the worst and ...
Edit

VTv Therapeutics: Q2 Earnings Snapshot

Daily Advance 13 Aug 2025
HIGH POINT, N.C. (AP) — HIGH POINT, N.C. (AP) — VTv Therapeutics Inc. (VTVT) on Tuesday reported a loss of $6 million in its second quarter ... .
Edit

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Nasdaq Globe Newswire 12 Aug 2025
• First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026 ... .
Edit

vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update (Form 8-K) (vTv Therapeutics Inc)

Public Technologies 12 Aug 2025
) vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update ... HIGH POINT, N.C., August 12, 2025 (GLOBE NEWSWIRE) - vTv Therapeutics Inc ... vTv Therapeutics Inc ... vTv Therapeutics Inc ... About vTv Therapeutics.

Article Search

tools
×
×
×
×